Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.

However, it is important to note that the survival analysis based on PAM50 subtypes did not reach statistical significance, limiting its use in prognostic prediction.

also in 111,027 other papers